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Abstract
 
Notch signaling has been shown to play a pivotal role in inducing T lineage commitment.
However, T cell progenitors are known to retain other lineage potential long after the first
point at which Notch signaling is required. Thus, additional requirements for Notch signals
and the timing of these events relative to intrathymic differentiation remain unknown. Here,
we address this issue by culturing subsets of CD4 CD8 double negative (DN) thymocytes on
control stromal cells or stromal cells expressing Delta-like 1 (Dll1). All DN subsets were found
to require Notch signals to differentiate into CD4
 
  
 
CD8
 
  
 
T cells. Using clonal analyses, we
show that CD44
 
  
 
CD25
 
  
 
(DN2) cells, which appeared committed to the T cell lineage when
cultured on Dll1-expressing stromal cells, nonetheless gave rise to natural killer cells with a
progenitor frequency similar to that of CD44
 
  
 
CD25
 
  
 
(DN1) thymocytes when Notch signal-
ing was absent. These data, together with the observation that Dll1 is expressed on stromal cells
throughout the thymic cortex, indicates that Notch receptor–ligand interactions are necessary
for induction and maintenance of T cell lineage specification at both the DN1 and DN2 stages
of T cell development, suggesting that the Notch-induced repression of the B cell fate is tem-
porally separate from Notch-induced commitment to the T lineage.
Key words: thymus • T cell development • notch ligands • lymphopoiesis and lineage 
commitment • stromal cell lines
 
Introduction
 
A number of studies have demonstrated an essential role for
Notch signaling during the commitment of multipotent
hematopoietic progenitor cells (HPCs) to the T cell lineage
(1–4). Notably, bone marrow cells transduced to express the
constitutively active intracellular domain of Notch1 fail to
develop into B cells when injected into recipient mice, and
instead undergo ectopic T cell development in the bone
marrow (1). In contrast, mice with a conditional deletion of
Notch1 lack T cells, and B cells develop in the thymus of
these Notch1-deficient animals (2). In addition, several
studies have implicated the Notch signaling pathway in dif-
ferentiation events occurring after T cell lineage commitment,
including the regulation of TCR-
 
  
 
gene rearrangement (5)
and the 
 
   
 
versus 
 
   
 
(6), or CD4 versus CD8 (7–10), lineage
decisions. Taken together, these findings support the notion
that Notch signaling is essential for T lineage commitment
and can influence multiple stages of subsequent T cell devel-
opment. However, the role that Notch plays at the earliest
stages of thymocyte development leading up to T cell com-
mitment has not been addressed.
During ontogeny, lymphoid precursors that colonize the
thymic rudiment at day 12 of gestation resemble lymphoid
progenitors present in the bone marrow and show little ev-
idence of Notch activation (11), suggesting that B cell lineage
potential is lost immediately after entry into the thymus.
However, several studies have reported that T/NK cell bi-
potent progenitors can be found in the fetal liver (12–14)
and fetal blood (15, 16), indicating that Notch signaling
resulting in the initial loss of B cell potential may occur
extrathymically.  Furthermore, a number of studies have
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demonstrated a substantial NK cell lineage potential from
early progenitor thymocytes (17–22), supporting the no-
tion that T cells develop through a T/NK bipotent inter-
mediate. In this regard, the temporal regulation of Notch
signals that result in T cell commitment from bipotent and
multipotent progenitors remains unclear.
The earliest populations of progenitor thymocytes lack
cell surface expression of CD4 and CD8, and are therefore
referred to as double negative (DN) cells (23). The DN
population can be further subdivided by surface expression
of CD117 (c-kit), CD44, and CD25 (IL-2R
 
 
 
; reference
24). The CD117
 
  
 
CD44
 
  
 
CD25
 
  
 
(DN1) population of
progenitor thymocytes is thought to contain multipotent
lymphoid progenitors (25), as well as T- and NK cell–
restricted bipotent, and perhaps unipotent, progenitors
(19, 26). In contrast, CD117
 
  
 
CD44
 
  
 
CD25
 
  
 
(DN2) thy-
mocytes give rise only to T cells when transferred to fetal
thymic organ culture or injected into recipient mice (27,
28), and therefore this population is generally thought to
represent a population of T lineage–committed precursors.
However, it has also been suggested that the DN2 popula-
tion contains progenitors that are specified to the T cell lin-
eage due to the expression of T lineage–specific genes (29),
but that are not yet fully committed, as several groups have
reported limited NK and dendritic cell potential from DN2
cells (19, 30–32). CD117
 
  
 
CD44
 
  
 
CD25
 
  
 
(DN3) cells appear
to be fully committed to the T cell lineage, as evidenced by
their ongoing process of TCR gene rearrangement (33,
34). CD117
 
  
 
CD44
 
  
 
CD25
 
  
 
(pre–double positive [DP])
cells are the product of DN3 cells that have undergone 
 
 
 
selection after successful TCR-
 
  
 
gene rearrangement (35),
and have already initiated the process of differentiating to
the DP stage (36, 37).
We have recently demonstrated that ectopic expression
of a Notch ligand, Delta-like 1 (Dll1), on the bone marrow
stromal cell line OP9 allows for the efficient differentiation
of fetal liver–derived HPCs into CD4 and CD8 DP T cells,
accompanied by the generation of a small population of
functionally mature CD8 single positive T cells (38). Fur-
thermore, OP9 cells expressing Dll1 (OP9-DL1) can sup-
port the differentiation and extensive proliferation of a sin-
gle progenitor cell with T or NK cell potential, whereas
the control OP9 cell line has a similar capacity to support
cells with B or NK cell potential, thus providing an ideal
system to specifically address the effect of Notch signaling
on the developmental potential of individual cells within
the DN subsets.
In this work, we have analyzed the developmental po-
tential and Notch signaling requirements of these DN thy-
mocyte subsets. For each of the DN subsets (DN1-3), the
program of T cell differentiation is arrested when cultured
on OP9-control cells, but is able to progress normally to
the DP stage when cultured on OP9-DL1 cells, indicat-
ing that Notch receptor–ligand interactions are required
throughout DN T cell development. We confirmed that
the DN1 population contains a substantial proportion of
cells that are bipotent for the T and NK cell lineages,
whereas only a relatively low frequency of DN1 cells pos-
sess B cell lineage potential. Furthermore, we demonstrate
that DN2 thymocytes have not undergone irreversible
commitment to the T cell lineage, but can instead adopt an
NK cell fate when cultured on OP9-control cells. Using
limiting dilution and clonal assays, we show that DN1 thy-
mocytes are more likely to adopt an NK cell fate in the ab-
sence of Notch receptor–ligand interactions, but that DN2
cells can only adopt the NK cell lineage when cultured in
the absence of Dll1.
Consistent with this dynamic view of Notch signaling
during T cell development, thymic stromal cells through-
out the cortex were found to express Dll1, highlighting the
requirement for continued and/or recurrent Notch recep-
tor–ligand interactions during all the initial stages of T cell
development. Finally, we show that pharmacological inhi-
bition of Dll1-induced Notch signals delayed T cell devel-
opment from HPCs, and resulted in a substantial increase in
the generation of NK cells with increasing concentrations
of inhibitor. Together, these findings indicate that Notch
signaling is necessary both for initial T cell specification at
the DN1 stage, and for T cell commitment at the DN2
stage. In addition, they suggest that Notch signals sequen-
tially restrict the lineage potential of progenitor cells, first
by extinguishing B lineage potential, and then by inducing
T/NK bipotent progenitors to adopt the T cell lineage.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice and timed-pregnant Swiss.NIH mice
were obtained from the National Cancer Institute, Frederick
Cancer Research and Development Center.
 
Cell Lines.
 
The OP9-control and OP9-DL1 cell lines were
generated, as described previously (38), by infecting the bone
marrow stromal cell line OP9 (39) with the empty MigR1 retro-
viral vector (1), or with the MigR1 retroviral vector engineered
to express the Dll1 gene (40) 5
 
  
 
of the internal ribosomal entry
site, allowing the bicistronic expression of Dll1 and GFP. OP9
cells, OP9-control cells, and OP9-DL1 cells were cultured as a
monolayer in OP9 media (
 
 
 
MEM supplemented with 20% FCS
[HyClone] and 2.2 g/liter sodium bicarbonate), to which IL-6,
IL-7, IL-15, and Flt3 ligand (all from PeproTech) were added to
enhance the growth of T, B, and NK cells.
 
Isolation of Fetal Cells.
 
Day 14 fetal thymus and fetal liver were
harvested, washed in 5 ml OP9 medium, and disrupted through
40-
 
 
 
m nylon mesh using a syringe plunger. CD24
 
low
 
/Lin
 
  
 
fetal
liver cells were obtained by antibody/complement-mediated lysis,
as described previously (16). In brief, 2 ml anti-CD24 (J11d.2) cul-
ture supernatant and a 1:10 dilution of Low-Tox rabbit comple-
ment (Cedar Lane) were added to single cell suspensions in 10 ml
complete medium, and cells were incubated at 37
 
 
 
C for 30 min.
After incubation, viable cells were recovered by discontinuous
density gradient centrifugation over Lympholyte-Mammal (Cedar
Lane) and washed before flow cytometric cell sorting.
 
Flow Cytometry and Cell Sorting.
 
Flow cytometry was per-
formed using a FACSCalibur™ (BD Biosciences) instrument, as
described previously (16). FITC-, PE-, biotin-, and APC-conju-
gated mAbs and streptavidin-APC were purchased from BD Bio-
sciences. For analysis, live cells were gated based on forward and
side scatter, and lack of propidium iodide uptake. Cells were 
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sorted using a FACSDiVa™ (BD Biosciences). Bulk-sorted cells
were 
 
 
 
99% pure, as determined by postsort analysis.
 
OP9 Cell Cocultures.
 
Fetal thymus DN subsets were sorted
based on the differential surface expression of CD117, CD44,
and CD25, as illustrated in Fig. 1 a. Sorted DN subsets were
seeded at 10
 
3 
 
cells/well into 24-well tissue culture plates contain-
ing either OP9-control or OP9-DL1 cells, to which 1 ng/ml IL-
6, 1 ng/ml IL-7, 25 ng/ml IL-15, and 5 ng/ml Flt3 ligand
were added to enhance the growth of T, B, and NK cells. The
cells were cultured for 7 d, and then analyzed by flow cytom-
etry. CD24
 
low
 
/Lin
 
  
 
fetal liver progenitor cells were sorted for
CD117
 
  
 
Sca-1
 
hi 
 
HPCs and cultured on either OP9-control or
OP9-DL1 cells. Various concentrations of the presenilin Inhibi-
tor X (Calbiochem) were added to the culture wells, as indicated
(see Fig. 4). The culture medium containing equal volumes of
DMSO alone or presenilin inhibitor (diluted in DMSO) was
changed on the fourth day of culture.
 
Precursor Frequency Analysis.
 
Limiting dilution analysis was
performed using the Clonecyte option of the FACSDiVa™ cell
sorter. As mentioned above, IL-6, IL-7, IL-15, and Flt3 ligand
were added to these assays to enhance the growth of T, B, and
NK cells. Precisely 1, 3, 10, 20, 30, or 100 DN1 and DN2 thy-
mocytes were deposited into 96-well plates containing OP9 cell
monolayers, with 56 replicate wells for each sample group of
DN1 cells and 53 replicate wells for each sample group of DN2
cells. Limiting dilution analysis was also performed using OP9-
DL1 cells by sorting 1, 3, 10, or 30 DN1 and DN2 thymocytes
into wells of 96-well plates containing OP9-DL1 cell monolay-
ers, with 24 replicate wells for each sample group. After 12–14 d,
the cells were harvested from individual wells and analyzed by
flow cytometry. The presence of CD45
 
  
 
NK1.1
 
  
 
CD19
 
  
 
NK
cells, CD45
 
  
 
NK1.1
 
  
 
CD19
 
  
 
B cells, and CD45
 
  
 
NK1.1
 
  
 
CD3
 
 
 
T cells was scored and the progenitor frequency was determined
by the method of maximum likelihood applied to the Poisson
model (41). Clonal assays were performed by depositing single
DN1 or DN2 thymocytes into individual wells of 96-well plates
containing OP9-DL1 cells by flow cytometric cell sorting. The
percentage of T cell progenitors, NK cell progenitors, and T/NK
bipotent progenitors within the DN1 and DN2 thymocyte pop-
ulations was determined flow cytometrically by analyzing the
phenotype of cell populations derived from single cells after 11–
14 d of culture (NK cell progenitors gave rise only to CD3
 
 
 
NK1.1
 
  
 
NK cells, T cell progenitors gave rise only to CD3
 
  
 
T
cells, and T/NK bipotent progenitors gave rise to both CD3
 
 
 
NK1.1
 
  
 
NK cells and CD3
 
  
 
T cells).
 
PCR and RT-PCR.
 
Genomic DNA was purified using the
EasyDNA kit (Invitrogen) from total day 14 fetal thymus, ex vivo
DN2 thymocytes, T cells derived from DN2 thymocytes cul-
tured on OP9-DL1, CD45
 
  
 
NK1.1
 
  
 
CD19
 
  
 
NK cells sorted
from DN2 cells cultured on OP9 cells for 14 d, and from embry-
onic fibroblasts. 100 ng of each DNA sample was amplified using
a PTC-225 Peltier Thermal Cycler (MJ Research). Primers used
for the TCR D-J
 
  
 
rearrangement analysis have been described
previously (42). Products were separated by agarose gel electro-
Figure 1. Developmental potential of early DN thymocytes cultured on OP9 bone marrow stromal cells in the presence (OP9-DL1) or absence (OP9-
control) of Dll1 expression. (a) Day 14 fetal thymocytes were sorted for the following populations: DN1 (R1-gated region A, CD117  CD44  CD25 ),
DN2 (R1-gated region B, CD117  CD44  CD25 ), and DN3 (R2-gated region C, CD117  CD44  CD25 ). (b) Thymocyte populations, sorted as in-
dicated, were cultured (1,000 cells/well) on OP9-control cells or OP9-DL1 cells for 7 d, and then analyzed for surface expression of the indicated lineage
markers by flow cytometry. Total cellularity is indicated in parentheses below each label. *, samples that could not be accurately counted by hemocytometer,
and for which cell counts were determined flow cytometrically. (c) Total number of DN2-derived NK cells generated from DN2 thymocytes cultured
on OP9-control and OP9-DL1 stromal cell lines. 
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phoresis and visualized by ethidium bromide staining. All PCR
products shown correspond to expected molecular sizes.
 
Immunofluorescent Staining of Thymus Sections.
 
Transverse fro-
zen sections of 5–6-wk-old C57BL/6 mouse thymus (5-
 
 
 
m
thickness) were prepared by embedding the tissue in OCT (Fisher
Scientific) followed by cryostatic sectioning onto glass slides. Sec-
tions were fixed in ice-cold acetone, dried, and rehydrated in
PBS. Endogenous avidin binding activity was blocked using Avi-
din/Biotin Blocking Kit (Vector Laboratories). Nonspecific pro-
tein binding was blocked using PBS containing 5% FBS. This
buffer was also used as diluent for all subsequent steps. Next, sec-
tions were stained with primary antibody, either goat polyclonal
IgG recognizing Dll1 (catalog no. SC9932; Santa Cruz Biotech-
nology, Inc.), or a matching concentration of nonimmune goat
IgG (Jackson ImmunoResearch Laboratories). Sections were
washed extensively and stained with biotinylated donkey anti-
serum raised against goat IgG (Jackson ImmunoResearch Labora-
tories), followed by blocking of excess secondary antibody bind-
ing sites using goat IgG. Sections were then stained with a
combination of streptavidin-conjugated Alexa 594 (Molecular
Probes) and FITC-conjugated anti-pancytokeratin (catalog no.
F3410; Sigma-Aldrich). After washing, nuclei were counter-
stained by mounting in Prolong solution (Molecular Probes) con-
taining DAPI (Molecular Probes). Single color images (DAPI,
FITC, and Alexa 594) were acquired on a fluorescent micro-
scope. Exposure times for each fluorochrome were kept the same
for both DL1 and control (nonspecific) primary antibodies. After
acquisition, single color images were merged to generate RGB
composites.
 
Online Supplemental Material.
 
Inhibition of Notch signaling
does not affect B or NK cell development on OP9-control cells.
See Fig. S1, which is available at http://www.jem.org/cgi/content/
full/jem.20040394/DC1.
 
Results
 
Requirement for Notch Receptor–Dll1 Interactions throughout
Early T Cell Development.
 
To characterize the require-
ment for Notch receptor–ligand interactions during early
thymocyte development, we sorted each of the three DN
thymocyte subsets before 
 
  
 
selection and cultured them
(1,000 cells/well) on either OP9-control or OP9-DL1 cells
for 7 d in conditions that effectively support T, B, and NK
cell growth (Fig. 1). As described previously, DN1 cells
contain multipotent lymphoid progenitors (27, 43), which,
when cultured on OP9-control cells, gave rise to B and
NK cells, but not T cells. In contrast, DN1 thymocytes
cultured on OP9-DL1 cells gave rise to both T and NK
cells, but not B cells (Fig. 1 b, left). DN1 cells proliferated
on both stromal cell lines; however, in the presence of
Dll1, this subset proliferated to a greater extent (148- vs.
1,150-fold expansion on OP9-control vs. OP9-DL1 cells,
respectively; Fig. 1 b).
Consistent with the notion that DN2 progenitors are
committed to the T cell lineage, this population failed to
give rise to B cells when cultured on OP9-control cells,
and T cells were observed almost exclusively when DN2
thymocytes were cultured on OP9-DL1 cells (Fig. 1 b,
middle). However, DN2 progenitors gave rise to a substan-
tial number of NK cells when cultured on OP9-control
cells, whereas only a few NK cells were generated from
DN2 cells cultured on OP9-DL1 cells (
 
 
 
15-fold more NK
cells on OP9-control vs. OP9-DL1 cells, respectively; Fig.
1 c). Therefore, our data supports the view that DN2 thy-
mocytes may not be fully committed to the T cell lineage,
and that these cells retain some plasticity toward the NK
cell lineage when cultured in an environment that does not
support further T cell commitment.
In contrast, DN3 cells, which bear irreversible hallmarks
of T lineage commitment in the form of TCR-
 
  
 
gene re-
arrangements (34), were no longer capable of adopting an
NK cell fate, failed to differentiate or expand on OP9-con-
trol cells (Fig. 1 b, right), and instead underwent cell death
(not depicted). On the other hand, DN3 cells cultured on
OP9-DL1 gave rise exclusively to T cells that progressed
normally to the DP stage (Fig. 1 b, bottom right). These
data show that a requirement for Notch signaling persists at
the DN3 stage, even though these cells are already com-
mitted to the T cell lineage, implying a role for Notch sig-
naling in functions other than lineage commitment (44).
 
Requirement for Notch Receptor–Dll1 Interactions during T
Cell Lineage Commitment by DN2 Thymocytes.
 
The results
in Fig. 1 b show that DN2 thymocytes do not appear to be
fully committed to the T cell lineage, as this population re-
tained the potential to give rise to an alternate cell fate un-
der conditions that do not support T cell development. To
determine the frequency of DN2 thymocytes that can dif-
ferentiate into NK cells, we performed a limiting dilution
analysis with DN2 and DN1 thymocytes cultured on OP9
cells. The results presented in Table I indicate that the NK
cell progenitor frequency within the DN1 population (1 in
8.8 DN1 cells) is similar to that of the DN2 population (1
in 13.6 DN2 cells). This analysis also revealed that the B
cell progenitor frequency within the DN1 subset appears to
be surprisingly small (1 in 188), and as demonstrated in Fig.
1 b, DN2 cells do not contain any B cell lineage potential.
Taken together, these data suggest that the majority of cells
within the DN1 population are either committed T cell
progenitors or bipotent T/NK cell progenitors, and that al-
though the transition from the DN1 to DN2 stage results
 
Table I.
 
Progenitor Frequency Analysis for DN1 and DN2 
Thymocytes Cultured on OP9 Cells
 
Subset
 
 →
 
 lineage analyzed
 
a
 
Progenitor Frequency
 
 
 
1
 
[95% confidence limits]
 
b
 
DN1 
 
→
 
 
 
B cells 188 [133–266]
DN1 
 
→
 
 
 
NK cells 8.8 [7.2–10.7]
DN2 
 
→
 
 
 
NK cells 13.6 [11.0–16.7]
 
a
 
Individual wells (
 
n 
 
  
 
56 wells with DN1 cells or 
 
n 
 
  
 
53 wells with
DN2 cells for each of the titrations, 100, 30, 20, 10, 3, and 1 cell/well)
were analyzed for the generation of B cells (CD19
 
 
 
) and NK cells
(NK1.1
 
 
 
; see Fig. 1).
 
b
 
Statistical analysis was performed using the method of maximum like-
lihood applied to the Poisson model. 
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in a loss of B cell potential, it does not result in a substantial
loss of NK cell lineage potential. This, in turn, suggests that
continued Notch signals specifying T cell lineage fate are
required at the DN2 stage.
To determine the relative frequency of committed T cell
progenitors, NK cell progenitors, and bipotent T/NK cell
progenitors within the early DN thymocyte subsets, we per-
formed a clonal assay, in which single DN1 or DN2 thy-
mocytes were placed into individual wells containing OP9-
DL1 cells (Fig. 2). T cell lineage potential was determined by
CD3 expression, and NK cell lineage potential was deter-
mined by the expression of NK1.1 in the absence of CD3
(Fig. 2 c). The frequency of T cell progenitors, NK cell pro-
genitors, and bipotent T/NK cell progenitors within the
DN1 and DN2 populations is shown in Fig. 2 a. These re-
sults indicate that the DN1 and DN2 subsets both contain a
relatively high frequency of progenitors that give rise exclu-
sively to T cells (27 out of 192 wells or 
 
 
 
51% of the total
number of reconstituted wells for DN1; 37 out of 192 wells
or 
 
 
 
90% of reconstituted wells for DN2), whereas the DN1
subset contained a greater percentage of NK cell lineage–
only progenitors than the DN2 subset (11 out of 192 wells
or 
 
 
 
21% of reconstituted for DN1; 4 out of 192 wells or
 
 
 
10% of reconstituted for DN2). Notably, bipotent T/NK
cell progenitors were only observed in wells seeded with
DN1 thymocytes (15 out of 192 wells or 
 
 
 
28% of reconsti-
tuted), whereas bipotent T/NK cell progenitors were not
detected within the DN2 thymocyte subset (Fig. 2 a).
These results appear in contrast to the limiting dilution
data presented in Table I, which clearly demonstrated a
similar progenitor frequency for NK cells (either bipotent
or NK cell lineage committed) within the first two DN
thymocyte subsets. To determine whether the presence of
Dll1 influences the ability of DN2 thymocytes to adopt the
NK cell fate, an additional limiting dilution analysis was
performed using OP9-DL1 cells to determine the progeni-
tor frequency for T and NK cells within the DN1 and
DN2 subsets (Table II).
The data shown in Fig. 2 b provides a comparison of
the NK cell progenitor frequencies from the limiting dilu-
tion analysis of each population (from Tables I and II)
when cultured on either control-OP9 cells (Fig. 2 b, left)
Figure 2. Clonal analysis of T and/or
NK cell progenitor potential from DN1
and DN2 thymocytes cultured on OP9
bone marrow stromal cells in the presence
(OP9-DL1) or absence (OP9-control)
of DL1 expression. (a) Single DN1
(CD117   CD44   CD25 ) and DN2
(CD117   CD44   CD25 ) thymocytes
were sorted into 96-well plates contain-
ing OP9-DL1 cells, and then cultured
for up to 14 d. Clonal populations were
analyzed by flow cytometry to deter-
mine the developmental potential of the
individually sorted cells (as shown in c).
Wells that contained only CD3  NK1.1 
NK cells were scored as NK restricted,
wells that contained only CD3  T cells
were scored as T cell restricted, and
wells that contained both CD3 
NK1.1   NK cells and CD3   T cells
were scored as T/NK cell bipotent. 192
wells, each containing a single DN1 or
DN2 cell, were analyzed for each popu-
lation, and the total number of wells
scoring positive for the presence of T,
NK, or both T and NK cells are illustrated
(left). The frequency of each progenitor
type is also presented as a percentage of
the total number of wells that success-
fully reconstituted (right). (b) A compari-
son of the NK cell progenitor frequency
observed for DN1 and DN2 cells when
cultured on either OP9-control (left) or
OP9-DL1 cells (middle), and the T cell
progenitor frequency observed for DN1
and DN2 cells when cultured on OP9-
DL1 cells (right). The data shown were
obtained from the limiting dilution anal-
ysis presented in Tables I and II. (c) Rep-
resentative flow cytometric analysis of
individual wells seeded with a single cell
with NK cell (left), T cell (middle), and
T/NK bipotent (right) potential. 
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or OP9-DL1 cells (Fig. 2 b, middle), as well as the T cell
progenitor frequency for each population (Fig. 2 b, right).
This analysis shows that the NK cell progenitor frequency
was only slightly decreased for DN2 thymocytes as com-
pared with DN1 thymocytes when cultured on OP9-con-
trol cells (11.4 to 7.4%, equivalent to only a  1.5-fold
higher NK cell progenitor frequency in the DN1 subset),
whereas there was a striking loss of NK cell progenitor
frequency between the two thymocyte subsets when as-
sayed on OP9-DL1 (4.3 to 0.3%, equivalent to a  15-fold
higher NK cell progenitor frequency in the DN1 subset).
As demonstrated in Fig. 2 a, the only NK cell potential
detectable from single DN2 cells cultured on OP9-DL1
cells was derived from a small number of contaminating
NK cell progenitors, suggesting that a proportion of com-
mitted NK cell progenitors in the thymus may express
CD25, and thus cannot be distinguished from DN2 thy-
mocytes. Therefore, the relatively high NK cell progeni-
tor frequency observed from the DN2 population when
cultured on control OP9 cells is likely derived from T cell
progenitors, which can adopt an NK cell fate in the ab-
sence of continued Notch receptor–ligand interactions. In
contrast, the progenitor frequency for T cells is not signif-
icantly different between the DN1 and DN2 subsets (66
and 64%, respectively) when cultured on OP9-DL1 cells
(Fig. 2 b, right).
Notably, the NK cell progenitor frequency of the DN2
population is  25-fold higher when assayed on OP9-con-
trol versus OP9-DL1 cells. It is also important to note that
the measured frequency of NK cell progenitors within the
DN1 population is  2.5-fold higher when cultured on
OP9-control versus OP9-DL1 cells, indicating that although
T/NK cell bipotent progenitors are readily detected from
DN1 cells cultured on OP9-DL1 (Fig. 2 a), Notch signaling
acts at the DN1 stage to promote T lineage specification at
the expense of NK cell development. Taken together, these
data indicate that Notch receptor–ligand interactions direct
T cell development throughout the DN1 and DN2 stages,
and that the DN2 population contains progenitors that are
specified to the T cell lineage, and thus require continuous
Notch signaling both to maintain T lineage specification and
to undergo final lineage commitment.
Status of the TCR-  Gene Rearrangement in NK Cells
Derived from DN2 Cells. Progenitor thymocytes begin the
process of TCR gene rearrangement during the DN2 to
DN3 transition (33, 34, 45, 46). Once thymocytes rear-
range their TCR genes, they are considered irreversibly
committed to the T cell lineage. The TCR-  gene locus of
DN2 cells is in the germline configuration, although a
small percentage of these cells have initiated the rearrange-
ment process and display TCR D-J  rearrangements (33,
34, 45, 46). To determine which DN2 cells are capable of
giving rise to NK cells when cultured on OP9 cells lacking
Dll1 expression, DN2 thymocytes were cultured for 2 wk
on OP9 cells, and the resulting NK cells were analyzed
for D-J  rearrangement by PCR (Fig. 3). Multiple D-J 
rearrangements were observed from fetal thymus–derived
DNA, and from DNA derived from DN2 thymocytes cul-
tured on OP9-DL1. In contrast, the genomic DNA from
DN2-derived NK cells produced a single PCR product
corresponding to the expected size of the germline locus,
like that observed from the DNA of fibroblasts (Fig. 3).
These results indicate that DN2 thymocytes that are re-
moved from a Notch ligand–containing environment are
unable to undergo TCR gene rearrangement and further-
more, DN2 thymocytes that have begun TCR gene rear-
Table II. Progenitor Frequency Analysis for DN1 and DN2 
Thymocytes Cultured on OP9-DL1 Cells
Subset → lineage analyzeda
Progenitor frequency 1
[95% confidence limits]b
DN1 → NK cells 23.1 [15.8–33.8]
DN2 → NK cells 340 [107–1,080]
DN1 → T cells 1.51 [1.03–2.21]
DN2 → T cells 1.56 [1.07–2.28]
aIndividual wells (n   24 wells for each of the titrations, 30, 10, 3, and
1 cell/well) were analyzed for the generation of T cells (CD3 ) and
NK cells (CD3  NK1.1 ; see Fig. 2 c).
bStatistical analysis was performed using the method of maximum like-
lihood applied to the Poisson model.
Figure 3. PCR analysis of DN2-derived NK cells for TCR-  gene rear-
rangements. DN2 (CD117  CD44  CD25 ) thymocytes were cultured on
OP9-control or OP9-DL1 cells for 14 d. DNA was purified from total
DN2-derived T cells (from OP9-DL1 cultures) and from DN2-derived NK
cells (from OP9-control cultures). The rearrangement status of the TCR- 
gene locus was determined by PCR using D 2-J 2 specific primers. PCR
reactions containing DNA from day 14 fetal thymus and fibroblast DNA
were included as TCR-rearranged and germline controls, respectively.Schmitt et al. 475
rangement may no longer be capable of adopting an NK
cell fate when transferred to an environment lacking Notch
receptor–ligand interactions.
Different Thresholds of Notch Signaling Are Required during
T Cell Lineage Commitment and Development. To further
elucidate the effect of Notch signaling during the initial
stages of T cell lineage commitment, we cultured CD117 
Sca-1hi fetal liver–derived HPCs on OP9-DL1 cells in the
presence of increasing concentrations of a presenilin 1 and 2
inhibitor. A presenilin-dependent   secretase activity is re-
quired for the cleavage of the intracellular transactivating do-
main of all four mammalian Notch receptors in response to
engagement by ligand (47). Fig. 4 shows that HPCs cultured
on OP9-DL1 cells in the absence of the presenilin 1/2 in-
hibitor (DMSO alone) failed to give rise to B lineage CD19 
cells, while efficiently generating primarily DN3 and pre-
DP/DP T lineage cells and a small percentage of NK1.1 
NK cells after 7 d of culture. However, in the presence of
increasing concentrations of the inhibitor there was a striking
increase in the proportion of NK cells generated on OP9-
DL1 cells (Fig. 4 a), which also correlated with a substantial
increase in the absolute number of NK cells in the cultures
(Fig. 4 c). Importantly, the effect on T versus NK cell devel-
opment occurred at lower concentrations of inhibitor than
was necessary to allow B cells to develop (Fig. 4 a). Further-
more, progression through the DN stages of T cell develop-
ment was also impaired or delayed in the presence of low
levels of inhibitor (Fig. 4 b). These results suggest that pro-
genitors require relatively high levels of Notch signaling to
initiate commitment to the T cell lineage and progress
through the DN stages of development, such that at even
low inhibitor concentrations, an increase in the generation of
NK cells becomes apparent. On the other hand, it appears
that the adoption of the B cell lineage by HPCs is sensitive to
even low levels of Notch signaling, such that B cells only de-
velop in the presence of the highest concentrations of the
presenilin 1/2 inhibitor. The addition of presenilin 1/2 in-
hibitor to HPCs cultured on OP9-control cells had no effect
on NK or B cell development (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20040394/DC1).
The finding that continuous Notch signaling is required
for T cell commitment and during the initial DN stages of T
cell development suggests that a Notch ligand must be ex-
pressed throughout the thymic cortex, where early T cell de-
velopment occurs. Therefore, we analyzed transverse sections
of adult thymus for the expression of Dll1 (Fig. 5). Cortical
epithelial cells, which are present throughout the thymic
cortex, were found to express Dll1, particularly near the cor-
tico-medullary junction, as staining for Dll1 and cytokeratin
colocalized on the same stromal cells. These findings are con-
sistent with those reported by Harman et al. (48), in which
transcripts for the different Notch ligands, including Dll1,
were shown to be expressed by thymic stromal cells. Because
cortical stromal cells provide the matrix for adhesion and mi-
gration of DN cells across the cortex (49), this pattern of Dll1
expression shows that Dll1 is in the position to provide the
necessary Notch signals that induce and support the commit-
ment and early development of T cells within the thymus.
Figure 4. Inhibition of Notch
signaling blocks T cell develop-
ment and promotes NK cell de-
velopment. CD117  Sca-1hi day
14 fetal liver HPCs were cul-
tured on OP9-DL1 cells for 7 d
with DMSO alone, or in the
presence of Inhibitor X, a prese-
nilin 1/2 inhibitor, at the indi-
cated concentrations. (a) Cells
from these cultures were analyzed
by flow cytometry for the pres-
ence of CD19  NK1.1  B cells
and CD19   NK1.1   NK cells.
(b) CD19  cells from these cul-
tures were electronically gated
and analyzed for the expression of
CD44 and CD25. (c) Total num-
ber of NK cells generated from
1.5     103  HPCs cultured on
OP9-DL1 stromal cell lines for
7 d in the absence (DMSO
alone) or presence of Inhibitor X
at the indicated concentrations.
The data are representative of at
least three independent trials.Maintenance of T Cell Specification and Differentiation Requires Notch 476
Discussion
In this work, we demonstrate that Notch signals are re-
quired at each of the early DN stages of thymocyte develop-
ment because the DN1-3 subsets could progress to subse-
quent T cell developmental stages only when cultured on
stromal cells expressing Dll1, but not when transferred to
OP9 cells that lack Dll1 expression. The DN2 population is
generally thought to represent the earliest thymocyte popu-
lation that is committed to the T cell lineage (50). Therefore,
we were surprised to find that a robust population of NK
cells developed from DN2 cells cultured on OP9-control
cells. This observation suggested that DN2 cells retain some
plasticity under certain conditions. In fact, previous studies
have also noted that DN2 thymocytes may possess some po-
tential for NK cell development (19, 27, 51). However, the
contribution of Notch signals to the NK cell progenitor fre-
quency from early DN thymocytes was not addressed.
As opposed to previously reported assay systems (19), the
OP9/OP9-DL1 cell lines represent a simple, well-defined sys-
tem that is ideally suited to address such questions (52). Col-
lectively, these cell lines can support the differentiation of all
lymphocyte lineages coupled with robust cellular expansion,
allowing limiting dilution analysis and powerful clonal assays
to be performed. Using this approach, we were surprised to
find that both DN1 cells and DN2 cells displayed a similar,
relatively high NK cell progenitor frequency when cultured in
the absence of Dll1-induced signals. Furthermore, we ob-
served a very low B cell progenitor frequency ( 0.5%) from
the DN1 population, indicating that the purported common
lymphoid progenitor within the DN1 population must be rel-
atively rare or may not exist within the fetal thymus (53).
To determine whether the NK cell potential within the
DN1 and DN2 populations was derived from T/NK cell
bipotent or NK cell lineage–committed progenitors, a
clonal assay using OP9-DL1 cells was used. Although our
results revealed that NK cell–committed precursors could
be found in both populations, we found that DN1 cells
have twice the frequency of NK cell–committed progeni-
tors than that observed for DN2 cells (Fig. 2). However, al-
though  60% of the total NK cell progenitor activity from
DN1 cells was derived from T/NK cell bipotent progeni-
tors, a striking absence of bipotent progenitors was noted
from the DN2 subset, such that the only NK cell potential
was derived from a small number of likely contaminating
NK cell–committed progenitors. These results indicate that
DN2 cells, which were shown to possess substantial NK
cell lineage potential when cultured on OP9-control cells
(Fig. 1 b and Table I), are unable to effectively adopt an
NK cell fate when cultured in the presence of Dll1.
Limiting dilution analyses of DN1 and DN2 thymocytes
cultured on OP9-DL1 cells revealed a decrease in the ob-
served NK cell progenitor frequency for both the DN1 and
DN2 subsets than that observed on OP9-control cells.
These results are consistent with the notion that Notch acts
to direct T cell fate throughout early thymocyte develop-
ment. However, Notch receptor–ligand interactions re-
sulted in a dramatic 25-fold reduction in the frequency of
Figure 5. Analysis of Dll1 expres-
sion by thymic epithelial cells. Im-
munofluorescent staining of thymus
sections reveals that Dll1 (top left,
red) is expressed in a reticular pattern
in the thymic cortex (in all panels,
the capsule is in the extreme top left
corner and the medulla begins in the
bottom right corner, with the cortico-
medullary junction indicated by the
yellow dotted line). This pattern of
expression is mirrored by cortical
stromal cells that express cytokeratin
(bottom left, green), as can be seen
when the Dll1 and cytokeratin images
are merged (top right, counterstained
with DAPI, blue). Expression of Dll1
generally appears to be strongest in
the deep cortex, but is present
throughout the cortex on most
cytokeratin  stromal cells. The bottom
right panel shows a serial section of
the same thymus stained with a non-
specific control antibody of the same
isotype and concentration as the
Dll1 antibody.Schmitt et al. 477
NK cell lineage potential from DN2 thymocytes, whereas
the effect of Notch was less pronounced at the DN1 stage,
resulting in only an  2.5-fold decrease in the frequency of
NK cell lineage potential in the presence of Dll1. Taken
together, these findings point to a mechanism whereby
Notch receptor–ligand interactions maintain T cell specifi-
cation by suppressing the remaining potential of DN2 thy-
mocytes to adopt an NK cell fate.
Our data suggests that the DN1 subset contains bipotent
T/NK cell progenitors that undergo a stochastic cell fate
choice, which might be biased toward the T cell lineage in
the presence of Notch signaling. On the other hand, speci-
fied DN2 thymocytes can only adopt the NK cell lineage
when Notch receptor–ligand interactions are interrupted,
such as by transfer to OP9 cells that lack Dll1 expression.
These findings shed light on earlier studies in which DN2
cells cultured in fetal thymic organ culture developed pre-
dominantly into T cells (27), or in which a low frequency
of NK cell lineage potential could be detected from DN2
cells using a modified (yet still able to strongly induce
Notch signals) fetal thymic organ culture system (19). As
demonstrated by Wolfer et al. (5), Notch1 signaling is also
essential for TCR-  gene rearrangement, which likely co-
incides with T cell lineage commitment. This notion is
supported by our findings that the TCR-  gene locus of
DN2-derived NK cells is in the germline configuration
(Fig. 3), indicating that DN2 thymocytes with TCR-D-J 
rearrangements may not readily adopt an NK cell fate.
Changes in the strength and duration of Notch signals
can influence cell fate choices during development (54).
We demonstrate that low levels of pharmacological inhibi-
tion of Notch signaling during fetal liver–derived HPC dif-
ferentiation on OP9-DL1 cells results in a partial block of
the T cell lineage developmental pathway, and preferen-
tially promotes the development of NK cells (Fig. 4). In
contrast, B cells develop on OP9-DL1 cells only in the
presence of high concentrations of the presenilin 1/2 in-
hibitor. Importantly, lymphoid progenitors in the fetal liver
express a level of Notch1 comparable to fetal DN1 and
DN2 thymocytes (11). Thus, it is likely that the observed
differences in sensitivity to the presenilin 1/2 inhibitor cor-
relates with the sensitivity to Notch signaling at different
developmental stages.
In contrast to the established role that Notch plays in T
versus B cell fate determination, the subsequent effect that
Notch signaling may play in T versus NK cell differentia-
tion has been overlooked. However, a number of studies
have demonstrated the presence of lymphoid progenitors
that are restricted to the T and NK cell lineages at various
extrathymic sites of hematopoietic development (12–16,
55). The notion that these progenitors require Notch sig-
naling to develop is supported by the well-established role
of Notch in blocking B cell potential, while directing the
differentiation of multipotent progenitors toward the T lin-
eage (4). However, Harman et al. (11) have recently dem-
onstrated that IL-7R   Lin  lymphoid progenitors from
the fetal liver exhibit only low levels of Notch activation,
and migrant lymphoid precursors in the perithymic mesen-
chyme of day 12 embryos lack clear evidence of Notch
activation before thymic entry. Thus, it remains unclear
when T cell progenitors that seed the thymus lose B cell
lineage potential.
Our results show that inhibition of B lymphopoiesis re-
quires low levels of Notch signaling, whereas the induction
of T lymphopoiesis requires high levels of Notch signaling.
Therefore, entry into the thymus may not be required to
extinguish B cell potential. Rather, HPCs may lose B cell
lineage potential in response to low levels of Notch activa-
tion in the fetal liver or in the adult bone marrow, but are
unable to undergo further T lineage differentiation before
thymic entry. Thus, several days may separate the Notch
signal that results in the loss of B cell potential and the sus-
tained Notch signaling that leads to T lineage commitment.
These distinct and temporally separable Notch signaling
events are consistent with our new understanding of the
time period (up to 10 d) required for DN1 cells to transit to
the DN2 stage within the adult thymus (56).
The requirement for high levels of Notch ligand–induced
signaling for the maintenance of T cell development within
the thymus is confirmed by our results showing that Dll1 is
expressed throughout the thymic cortex and, in particular,
found to be expressed at higher levels near the cortico-med-
ullary junction (Fig. 5), which is the site where incoming
progenitors would first encounter the thymic stroma (57).
Our data does not rule out that other unknown factors, in-
cluding other Delta-like family members (such as Delta-like
4), may also play an important role in the induction and
maintenance of T cell development in the thymus. Never-
theless, our findings suggest that thymocytes require con-
stant contact with Notch ligand–bearing thymic epithelial
cells to progress through early T cell differentiation. In
keeping with this, it has recently been shown that thy-
mocytes use cortical stromal cells as a matrix for transmigra-
tion across the cortex during differentiation, and thus main-
tain intimate contact with such stromal cells throughout
their differentiation (49). Because these are the same stromal
cells that we now find to express Dll1, it appears that one
critical reason for using a stromal cell matrix for migration
rather than an extracellular one, is to enforce continuous
Notch signaling throughout the differentiation process.
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